Results 31 to 40 of about 486,907 (280)

Tumor associated antigens in diagnosis of serous effusions [PDF]

open access: yes, 1988
The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patients with benign and 200 patients with malignant disease.
Permanetter, W.   +4 more
core   +1 more source

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

open access: yesCase Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino   +8 more
doaj   +1 more source

Pleural Effusions in Hematologic Malignancies

open access: yesChest, 2004
Nearly all hematologic malignancies can occasionally present with or develop pleural effusions during the clinical course of disease. Among the most common disorders are Hodgkin and non-Hodgkin lymphomas, with a frequency of 20 to 30%, especially if mediastinal involvement is present.
Alexandrakis, MG   +3 more
openaire   +3 more sources

Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax

open access: yesChinese Medical Journal, 2015
Background: Hydrothorax, as one of the common complications of malignant tumors, still cannot be sensitively detected in clinical practice, thus requiring a sensitive, specific method for diagnosis.
Yan Gu   +10 more
doaj   +1 more source

Ultrasonographic Features of Pleural Thickening in Cats With Pulmonary Carcinoma and Pleural Effusion: A Retrospective Descriptive Study [PDF]

open access: yesVet Med Sci
In cats with pulmonary carcinoma and pleural effusion, thoracic ultrasonography identified pleural thickening with variable morphology. In selected cats, thickened pleura or pleura‐associated lesions provided accessible targets for ultrasound‐guided sampling, supporting their potential role in diagnosis.
Toshima A, Fulkerson C, Murakami M.
europepmc   +2 more sources

Management of pleural effusion secondary to malignant mesothelioma [PDF]

open access: yes, 2021
Malignant pleural mesothelioma (MPM) is a highly aggressive pleural tumour which has been epidemiologically linked to occupational exposure to asbestos.
Alberto Aiolfi   +11 more
core   +2 more sources

Reactive oxygen species modulator 1, a novel protein, combined with carcinoembryonic antigen in differentiating malignant from benign pleural effusion

open access: yesTumor Biology, 2017
The differential diagnosis of malignant pleural effusion and benign pleural effusion remains a clinical problem. Reactive oxygen species modulator 1 is a novel protein overexpressed in various human tumors. The objective of this study was to evaluate the
Xianmeng Chen   +3 more
doaj   +1 more source

Multiplexed serpentine microchannels for high-throughput sorting of disseminated tumor cells from malignant pleural effusion

open access: yes, 2021
Accurate isolation and detection of disseminated tumor cells from the malignant pleural effusion (MPE) is of significant clinical importance. Cytology is a routine diagnostic tool for the analysis of MPE.
Zhu, Zhixian   +23 more
core   +1 more source

The Diagnostic Value of carcinoembryonic Antigen and cancer Antigen 125 in Malignant Pleural Effusion [PDF]

open access: yesZagazig University Medical Journal
Many studies have proved that carcinoembryonic antigen (CEA) and cancer antigen 125 (CA125) have high affinity and binding specificity, and can be used to distinguish pleural effusion in patients with malignant and non-malignant pleural effusion.
Adel Elghamrawy   +3 more
doaj   +1 more source

The spectral slope curve of benign pleural effusion and malignant pleural effusion.

open access: yes, 2018
The spectral slope curve of benign pleural effusion and malignant pleural effusion.
Yuxin Lei (5088806)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy